Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Asset Writedowns and Impairment came in at $193000.0 in Q1 2026, down 38.54% YoY from $314000.0 in Q1 2025, and up 457.41% on a QoQ basis from -$54000.0 in Q4 2025.
Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Asset Writedowns and Impairment data on file, last reported at $193000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 38.54% year-over-year to $193000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $292000.0 (down 72.14% YoY) and the FY2025 annual result came in at $413000.0, down 74.91% from the prior year.
- Asset Writedowns and Impairment grew to $193000.0 in Q1 2026, from -$54000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.7 million in Q4 2024 to a low of -$985000.0 in Q2 2024.
- A 5-year average of $298400.0 and a median of $213000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment soared 467.24% — and 2024, when it sank 7135.71%.
- Tracing CTKB's Asset Writedowns and Impairment over 5 years: stood at $294000.0 in 2022, then jumped by 127.89% to $670000.0 in 2023, then surged by 156.57% to $1.7 million in 2024, then slumped by 103.14% to -$54000.0 in 2025, then jumped by 457.41% to $193000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $193000.0 (Q1 2026), -$54000.0 (Q4 2025), and $415000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 174,000.00 |
| Jun 30, 2026 | 174,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | -54,000.00 |
| Dec 31, 2025 | -54,000.00 |
| Sep 30, 2025 | 415,000.00 |
| Sep 30, 2025 | 415,000.00 |
| Jun 30, 2025 | -262,000.00 |
| Jun 30, 2025 | -262,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Dec 31, 2024 | 1.72 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Jun 30, 2024 | -985,000.00 |
| Jun 30, 2024 | -985,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Dec 31, 2023 | 670,000.00 |
| Dec 31, 2023 | 670,000.00 |